Nuvo Medsurg Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 4.40 M
as on 12-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.74 Cr
as on 12-12-2024
- Revenue 0.57%
(FY 2023)
- Profit -88.62%
(FY 2023)
- Ebitda -322.05%
(FY 2023)
- Net Worth -3091.74%
(FY 2023)
- Total Assets -25.81%
(FY 2023)
About Nuvo Medsurg
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.40 M.
The company currently has active open charges totaling ₹1.74 Cr.
Pankaj Bansal, Saurabh Goel, and Naresh Goyal serve as directors at the Company.
- CIN/LLPIN
U51900DL2013PTC253968
- Company No.
253968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nuvo Medsurg Private Limited offer?
Nuvo Medsurg Private Limited offers a wide range of products and services, including Sutures, Absorbable Sutures, Child and Baby Care Products, Baby Care Products, Non Absorbable Sutures.
Who are the key members and board of directors at Nuvo Medsurg?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Bansal  | Director | 04-Mar-2016 | Current |
| Saurabh Goel | Director | 14-Jun-2013 | Current |
| Naresh Goyal | Director | 14-Jun-2013 | Current |
Financial Performance of Nuvo Medsurg.
Nuvo Medsurg Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.57% increase. The company also saw a substantial fall in profitability, with a 88.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 3091.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuvo Medsurg?
In 2023, Nuvo Medsurg had a public holding of 74.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 29 May 2017 | ₹1.74 Cr | Open |
How Many Employees Work at Nuvo Medsurg?
Nuvo Medsurg has a workforce of 16 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuvo Medsurg, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvo Medsurg's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
